J&J’s Acuvue Contact Lenses Approved By FDA For Myopia Control

Johnson & Johnson Vision announced that the U.S. Food and Drug Administration has approved Acuvue Abiliti Overnight Therapeutic Lenses.

The company described the product as “the first and only FDA approved orthokeratology (ortho-k) contact lens for the management of myopia.”

“The FDA approval of Abiliti Overnight marks an important milestone in our commitment to help change the trajectory of eye health and reshape the future of children with myopia,” said Xiao-Yu Song, MD, PhD, global head of research and development, Johnson & Johnson Vision. “We look forward to supporting parents and eye care professionals in their care of children with comprehensive resources, starting with Abiliti Overnight Therapeutic Lenses, and continuing with additional products and services to address the progression of myopia.”

The lenses are expected to be available in the U.S. by the end of this year.

Current Issue

{page_title}Vote & Win with ZEISS 'You&Eye' Awards 2022

Eyewear Collection
Service Quality
Clinical Expertise
Overall Satisfaction

{page_title}Vote & Win with Zeiss You&Eye Awards 2022

Eyewear Collection
Service Quality
Clinical Expertise
Overall Satisfaction

Yes, it's possible to order your products online from

This feature will be launched soon ONLY FOR OPTICIANS.

Our team is working hard in the background to make this happen. We appreciate your patience.

If you'd like to be update when the feature goes live, feel free to share your contact details in the form provided.

Yes, it's possible to order your products online from

This feature will be launched soon for J&J’s Acuvue Contact Lenses Approved By FDA For Myopia Control 

In the meantime please use the Contact Form on the optician's page to send them a message.